The Motley Fool··Prosper Junior BakinyAbbott Labs Stock Slides 22% on Weak Diagnostics, But Dividend Investors See Opportunity
$ABT down 22% after disappointing earnings, but strong medical devices and $21B Exact Sciences deal offer recovery potential for income seekers.
ABTEXAShealthcaredividend stock